BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30496936)

  • 1. Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.
    Haque W; Arms A; Verma V; Hatch S; Brian Butler E; Teh BS
    Breast; 2019 Feb; 43():67-73. PubMed ID: 30496936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
    Mukhtar RA; Krings G; Chen YY; Mamounas ME; Fahrner-Scott K; Wong J; Alvarado M; Ewing C; Esserman LJ; Rugo H
    Breast Cancer Res Treat; 2020 May; 181(1):23-29. PubMed ID: 32240457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
    Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
    Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis.
    Liu YL; Choi C; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
    Clin Breast Cancer; 2018 Apr; 18(2):114-120. PubMed ID: 28720418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Real-world Outcomes of Patients With Advanced Invasive Lobular Carcinoma of the Breast Compared With Invasive Ductal Carcinoma: A Review at a Single Institution.
    Watanabe J; Nakamoto S; Sugino T
    Anticancer Res; 2021 Sep; 41(9):4619-4627. PubMed ID: 34475090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
    Tamirisa N; Williamson HV; Thomas SM; Westbrook KE; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Hwang ES; Fayanju OM
    J Surg Oncol; 2019 Aug; 120(2):132-141. PubMed ID: 31062375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.
    Sestak I; Filipits M; Buus R; Rudas M; Balic M; Knauer M; Kronenwett R; Fitzal F; Cuzick J; Gnant M; Greil R; Dowsett M; Dubsky P
    Clin Cancer Res; 2020 Sep; 26(17):4682-4687. PubMed ID: 32561662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.
    Jacobs M; Fan F; Tawfik O
    Ann Diagn Pathol; 2012 Jun; 16(3):185-9. PubMed ID: 22197540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
    Kurozumi S; Alsaleem M; Monteiro CJ; Bhardwaj K; Joosten SEP; Fujii T; Shirabe K; Green AR; Ellis IO; Rakha EA; Mongan NP; Heery DM; Zwart W; Oesterreich S; Johnston SJ
    Breast Cancer Res; 2020 Aug; 22(1):85. PubMed ID: 32782013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
    Narendra S; Jenkins SM; Khoor A; Nassar A
    Ann Diagn Pathol; 2015 Apr; 19(2):64-9. PubMed ID: 25682191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
    Tan RYC; Ong WS; Lee KH; Park S; Iqbal J; Park YH; Lee JE; Yu JH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Koh J; Han W; Im SA; Tan VKM; Phyu N; Wong FY; Tan PH; Yap YS
    J Natl Compr Canc Netw; 2024 May; 22(2D):. PubMed ID: 38744306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma.
    Tille JC; Vieira AF; Saint-Martin C; Djerroudi L; Furhmann L; Bidard FC; Kirova Y; Tardivon A; Reyal F; Carton M; Vincent-Salomon A
    Mod Pathol; 2020 Nov; 33(11):2198-2207. PubMed ID: 32404955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of preoperative
    Higuchi T; Nishimukai A; Ozawa H; Fujimoto Y; Yanai A; Miyagawa Y; Murase K; Imamura M; Takatsuka Y; Kitajima K; Fukushima K; Miyoshi Y
    Breast; 2016 Dec; 30():5-12. PubMed ID: 27569020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.